Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2010 1
2011 3
2012 1
2013 1
2014 4
2015 4
2016 1
2017 1
2018 5
2019 3
2020 6
2021 13
2022 7
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of early-start deferiprone in infants and young children with transfusion-dependent beta thalassemia: Evidence for iron shuttling to transferrin in a randomized, double-blind, placebo-controlled, clinical trial (START).
Elalfy MS, Hamdy M, Adly A, Ebeid FSE, Temin NT, Rozova A, Lee D, Fradette C, Tricta F. Elalfy MS, et al. Among authors: ebeid fse. Am J Hematol. 2023 Sep;98(9):1415-1424. doi: 10.1002/ajh.27010. Epub 2023 Jul 4. Am J Hematol. 2023. PMID: 37401738 Clinical Trial.
Epistaxis in a Pediatric Outpatient Clinic: Could It be an Alarming Sign?
ElAlfy MS, Tantawy AAG, Eldin BEMB, Mekawy MA, Mohammad YAE, Ebeid FSE. ElAlfy MS, et al. Among authors: ebeid fse. Int Arch Otorhinolaryngol. 2021 Jun 3;26(2):e183-e190. doi: 10.1055/s-0041-1726040. eCollection 2022 Apr. Int Arch Otorhinolaryngol. 2021. PMID: 35602268 Free PMC article.
Deferiprone versus deferoxamine for transfusional iron overload in sickle cell disease and other anemias: Pediatric subgroup analysis of the randomized, open-label FIRST study.
Hamdy M, El-Beshlawy A, Veríssimo MPA, Kanter J, Inusa B, Williams S, Lee D, Temin NT, Fradette C, Tricta F, Ebeid FSE, Kwiatkowski JL, Elalfy MS. Hamdy M, et al. Among authors: ebeid fse. Pediatr Blood Cancer. 2024 Jan;71(1):e30711. doi: 10.1002/pbc.30711. Epub 2023 Oct 9. Pediatr Blood Cancer. 2024. PMID: 37807937 Clinical Trial.
Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study.
Dabbous HM, Abd-Elsalam S, El-Sayed MH, Sherief AF, Ebeid FFS, El Ghafar MSA, Soliman S, Elbahnasawy M, Badawi R, Tageldin MA. Dabbous HM, et al. Among authors: ebeid ffs. Arch Virol. 2021 Mar;166(3):949-954. doi: 10.1007/s00705-021-04956-9. Epub 2021 Jan 25. Arch Virol. 2021. PMID: 33492523 Free PMC article. Retracted. Clinical Trial.
Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study.
Kwiatkowski JL, Hamdy M, El-Beshlawy A, Ebeid FSE, Badr M, Alshehri A, Kanter J, Inusa B, Adly AAM, Williams S, Kilinc Y, Lee D, Tricta F, Elalfy MS. Kwiatkowski JL, et al. Among authors: ebeid fse. Blood Adv. 2022 Feb 22;6(4):1243-1254. doi: 10.1182/bloodadvances.2021004938. Blood Adv. 2022. PMID: 34847228 Free PMC article. Clinical Trial.
58 results